Game Creek Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.13M | Buy |
93,875
+13,800
| +17% | +$1.32M | 2.71% | 7 |
|
|
2025
Q4 | $7.69M | Buy |
80,075
+18,825
| +31% | +$1.83M | 2.54% | 7 |
|
|
2025
Q3 | $5.83M | Buy |
61,250
+42,750
| +231% | +$3.93M | 2.04% | 9 |
|
|
2025
Q2 | $1.61M | Buy |
18,500
+6,750
| +57% | +$572K | 0.69% | 49 |
|
|
2025
Q1 | $1.06M | Buy |
11,750
+8,500
| +262% | +$761K | 0.53% | 50 |
|
|
2024
Q4 | $260K | Sell |
3,250
-250
| -7% | -$21.6K | 0.1% | 81 |
|
|
2024
Q3 | $315K | Sell |
3,500
-2,375
| -40% | -$200K | 0.14% | 72 |
|
|
2024
Q2 | $462K | Sell |
5,875
-2,000
| -25% | -$164K | 0.24% | 63 |
|
|
2024
Q1 | $686K | Buy |
7,875
+1,625
| +26% | +$139K | 0.33% | 55 |
|
|
2023
Q4 | $515K | Sell |
6,250
-11,750
| -65% | -$896K | 0.22% | 62 |
|
|
2023
Q3 | $1.41M | Buy |
18,000
+5,750
| +47% | +$481K | 0.87% | 40 |
|
|
2023
Q2 | $1.08M | Sell |
12,250
-3,500
| -22% | -$301K | 0.61% | 44 |
|
|
2023
Q1 | $1.27M | Sell |
15,750
-16,750
| -52% | -$1.37M | 0.71% | 44 |
|
|
2022
Q4 | $2.53M | Buy |
32,500
+12,000
| +59% | +$973K | 1.45% | 28 |
|
|
2022
Q3 | $1.66M | Buy |
20,500
+750
| +4% | +$67.4K | 1.01% | 34 |
|
|
2022
Q2 | $1.77M | Sell |
19,750
-7,125
| -27% | -$722K | 0.94% | 35 |
|
|
2022
Q1 | $2.98M | Sell |
26,875
-2,625
| -9% | -$277K | 1.18% | 30 |
|
|
2021
Q4 | $3.05M | Buy |
29,500
+12,750
| +76% | +$1.48M | 1.27% | 26 |
|
|
2021
Q3 | $2.1M | Sell |
16,750
-3,125
| -16% | -$404K | 0.9% | 35 |
|
|
2021
Q2 | $2.47M | Sell |
19,875
-875
| -4% | -$110K | 1.24% | 30 |
|
|
2021
Q1 | $2.45M | Sell |
20,750
-3,125
| -13% | -$366K | 1.37% | 29 |
|
|
2020
Q4 | $2.8M | Buy |
23,875
+1,000
| +4% | +$110K | 1.65% | 19 |
|
|
2020
Q3 | $2.38M | Sell |
22,875
-15,625
| -41% | -$1.57M | 1.79% | 24 |
|
|
2020
Q2 | $3.53M | Buy |
38,500
+6,500
| +20% | +$623K | 2.89% | 17 |
|
|
2020
Q1 | $2.89M | Buy |
32,000
+10,250
| +47% | +$1.09M | 2.68% | 16 |
|
|
2019
Q4 | $2.47M | Sell |
21,750
-500
| -2% | -$54.9K | 1.39% | 27 |
|
|
2019
Q3 | $2.42M | Sell |
22,250
-8,000
| -26% | -$835K | 1.16% | 35 |
|
|
2019
Q2 | $2.95M | Sell |
30,250
-9,363
| -24% | -$855K | 1.7% | 27 |
|
|
2019
Q1 | $3.61M | Buy |
39,613
+3,363
| +9% | +$301K | 1.76% | 23 |
|
|
2018
Q4 | $3.3M | Sell |
36,250
-1,000
| -3% | -$93.4K | 1.55% | 28 |
|
|
2018
Q3 | $3.66M | Sell |
37,250
-7,750
| -17% | -$717K | 1.34% | 30 |
|
|
2018
Q2 | $3.85M | Sell |
45,000
-8,250
| -15% | -$689K | 1.64% | 29 |
|
|
2018
Q1 | $4.27M | Buy |
+53,250
| New | +$4.39M | 1.87% | 21 |
|
Other funds holding MDT
VCM
VPM
Game Creek Capital's MDT Position: Q1 2026 in Review
Game Creek Capital increased its Medtronic (MDT) stake by 17% in Q1 2026, buying an estimated $1.32M and bringing the position to 93,875 shares worth $8.13M. The position accounts for 2.71% of the portfolio, ranked #7.
Game Creek Capital first reported a position in MDT in Q1 2018 and has held it in 33 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Game Creek Capital held 93,875 shares of Medtronic worth $8.13M as of Q1 2026.
- Game Creek Capital bought 13,800 Medtronic shares in Q1 2026, an estimated $1.32M.
- Medtronic made up 2.71% of Game Creek Capital's portfolio in Q1 2026, its #7 holding.
- Game Creek Capital first reported a position in Medtronic in Q1 2018 and has held it in 33 quarters since.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Game Creek Capital's 13F filing for Q1 2026, filed 14 May 2026.